Stockreport

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 80% p.a. on average during the next 3 years [Read more]